A detailed history of Kelly Financial Services LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Kelly Financial Services LLC holds 182 shares of PRTA stock, worth $3,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares
182
Previous 182 -0.0%
Holding current value
$3,993
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024

SELL
$48.2 - $78.89 $442,235 - $723,815
-9,175 Reduced 98.05%
182 $13 Million
Q2 2021

Jul 17, 2024

BUY
$21.63 - $57.65 $198,455 - $528,938
9,175 Added 5041.21%
9,357 $182,000
Q1 2021

Jul 17, 2024

BUY
$11.0 - $28.24 $2,002 - $5,139
182 New
182 $4.57 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $1.03B
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.